Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/44407
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

The C/H3 Domain of p300 Is Required to Protect VRK1 and VRK2 from their Downregulation Induced by p53

AutorValbuena, A.; Blanco, Sandra CSIC ORCID CVN; Vega, Francisco M. CSIC ORCID; Lazo, Pedro A. CSIC ORCID
Fecha de publicación9-jul-2008
EditorPublic Library of Science
CitaciónPLoS ONE 3(7): e2649 (2008)
ResumenBackground The vaccinia-related kinase 1 (VRK1) protein, an activator of p53, can be proteolytically downregulated by an indirect mechanism, which requires p53-dependent transcription. Principal Findings In this work we have biochemically characterized the contribution of several p53 transcriptional cofactors with acetyl transferase activity to the induction of VRK1 downregulation that was used as a functional assay. Downregulation of VRK1 induced by p53 is prevented in a dose dependent manner by either p300 or CBP, but not by PCAF, used as transcriptional co-activators, suggesting that p53 has a different specificity depending on the relative level of these transcriptional cofactors. This inhibition does not require p53 acetylation, since a p53 acetylation mutant also induces VRK1 downregulation. PCAF can not revert the VRK1 protection effect of p300, indicating that these two proteins do not compete for a common factor needed to induce VRK1 downregulation. The protective effect is also induced by the C/H3 domain of p300, a region implicated in binding to several transcription factors and SV40 large T antigen; but the protective effect is lost when a mutant C/H3Del33 is used. The protective effect is a consequence of direct binding of the C/H3 domain to the transactivation domain of p53. A similar downregulatory effect can also be detected with VRK2 protein. Conclusions/Significance Specific p53-dependent effects are determined by the availability and ratios of its transcriptional cofactors. Specifically, the downregulation of VRK1/VRK2 protein levels, as a consequence of p53 accumulation, is thus dependent on the levels of the p300/CBP protein available for transcriptional complexes, since in this context this cofactor functions as a repressor of the effect. These observations point to the relevance of knowing the cofactor levels in order to determine one effect or another.
Versión del editorhttp://dx.doi.org/10.1371/journal.pone.0002649
URIhttp://hdl.handle.net/10261/44407
DOI10.1371/journal.pone.0002649
ISSN1932-6203
Aparece en las colecciones: (IBMCC) Artículos

Ficheros en este ítem:
Fichero Descripción Tamaño Formato
journal.pone.0002649.pdf701,94 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

PubMed Central
Citations

15
checked on 13-mar-2024

SCOPUSTM   
Citations

22
checked on 23-mar-2024

WEB OF SCIENCETM
Citations

22
checked on 22-feb-2024

Page view(s)

297
checked on 28-mar-2024

Download(s)

253
checked on 28-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.